Stephanie J Sohl1, Janet A Tooze2, Emily Nance Johnson2, Sheila H Ridner3, Russell L Rothman4, Caio Rocha Lima2, Katherine C Ansley2, Amy Wheeler5, Barbara Nicklas2, Nancy E Avis2, Lynne I Wagner2. 1. Wake Forest School of Medicine (S.J.S., J.A.T., E.N.J., C.R.L., K.C.A., B.N., N.E.A, L.I.W.), Winston-Salem, North Carolina, USA. Electronic address: ssohl@wakehealth.edu. 2. Wake Forest School of Medicine (S.J.S., J.A.T., E.N.J., C.R.L., K.C.A., B.N., N.E.A, L.I.W.), Winston-Salem, North Carolina, USA. 3. Vanderbilt University School of Nursing (S.H.R.), Nashville, Tennessee, USA. 4. Vanderbilt University School of Medicine (R.L.R.), Nashville, Tennessee, USA. 5. California State University (A.W.), San Bernardino, California, USA.
Abstract
CONTEXT: It is important to address fatigue and co-occurring symptoms during chemotherapy to preserve quality of life in patients with gastrointestinal (GI) cancer. OBJECTIVE: To conduct a randomized controlled pilot study of a Yoga Skills Training (YST) intervention compared to an attention control (AC) among adults diagnosed with GI cancer. METHODS: YST consisted of four 30-minute sessions delivered individually during chemotherapy plus home practice. AC provided empathic attention plus home diaries. Patient-reported (PROMIS T-score) assessments of fatigue, depressive symptoms, sleep disturbances, and psychological stress (Perceived Stress Scale) were collected at chemotherapy visits: baseline, Week 8, Week 10 and Week 14, and analyzed using a mixed effects model. Inflammatory cytokines were assessed at baseline and Week 10. RESULTS: Forty-four of 77 adults approached agreed to participate (57%; YST n = 23; AC n = 21). Participants' mean age was 58 years and 48% were men. Participants randomized to YST reported a larger decline in fatigue (-2.4 difference, d = 0.30) and depressive symptoms (-2.5 difference, d = 0.30) than AC participants from baseline to Week 10 and sleep disturbances at Week 8 (-3.9 difference, d = 0.50). Differences in magnitude of change in symptoms were consistent with or exceeded a minimally important difference. Psychological stress decreased more in the AC at Week 10 (d = 0.30). Reductions in inflammatory cytokines (IL-6, sTNF R1) were larger in the YST group than AC. CONCLUSION: YST showed promise for improving fatigue, depressive symptoms, sleep disturbances, and inflammation. YST is also feasible and reaches patients underrepresented in yoga research (i.e., GI cancer, men), thus warranting further examination.
CONTEXT: It is important to address fatigue and co-occurring symptoms during chemotherapy to preserve quality of life in patients with gastrointestinal (GI) cancer. OBJECTIVE: To conduct a randomized controlled pilot study of a Yoga Skills Training (YST) intervention compared to an attention control (AC) among adults diagnosed with GI cancer. METHODS: YST consisted of four 30-minute sessions delivered individually during chemotherapy plus home practice. AC provided empathic attention plus home diaries. Patient-reported (PROMIS T-score) assessments of fatigue, depressive symptoms, sleep disturbances, and psychological stress (Perceived Stress Scale) were collected at chemotherapy visits: baseline, Week 8, Week 10 and Week 14, and analyzed using a mixed effects model. Inflammatory cytokines were assessed at baseline and Week 10. RESULTS: Forty-four of 77 adults approached agreed to participate (57%; YST n = 23; AC n = 21). Participants' mean age was 58 years and 48% were men. Participants randomized to YST reported a larger decline in fatigue (-2.4 difference, d = 0.30) and depressive symptoms (-2.5 difference, d = 0.30) than AC participants from baseline to Week 10 and sleep disturbances at Week 8 (-3.9 difference, d = 0.50). Differences in magnitude of change in symptoms were consistent with or exceeded a minimally important difference. Psychological stress decreased more in the AC at Week 10 (d = 0.30). Reductions in inflammatory cytokines (IL-6, sTNF R1) were larger in the YST group than AC. CONCLUSION: YST showed promise for improving fatigue, depressive symptoms, sleep disturbances, and inflammation. YST is also feasible and reaches patients underrepresented in yoga research (i.e., GI cancer, men), thus warranting further examination.
Authors: Stephanie J Sohl; Gurjeet S Birdee; Sheila H Ridner; Amy Wheeler; Sandra Gilbert; Danielle Tarantola; Jordan Berlin; Russell L Rothman Journal: Int J Yoga Therap Date: 2016-01
Authors: Kurt Kroenke; Timothy E Stump; Jacob Kean; Tasneem L Talib; David A Haggstrom; Patrick O Monahan Journal: J Clin Epidemiol Date: 2019-07-19 Impact factor: 6.437
Authors: Xin Shelley Wang; Loretta A Williams; Sunil Krishnan; Zhongxing Liao; Ping Liu; Li Mao; Qiuling Shi; Gary M Mobley; Jeanie F Woodruff; Charles S Cleeland Journal: Brain Behav Immun Date: 2012-01-10 Impact factor: 7.217
Authors: James W Carson; Kimberly M Carson; Laura S Porter; Francis J Keefe; Heather Shaw; Julie M Miller Journal: J Pain Symptom Manage Date: 2007-03 Impact factor: 3.612
Authors: Alexander Haussmann; Martina E Schmidt; Mona L Illmann; Marleen Schröter; Thomas Hielscher; Holger Cramer; Imad Maatouk; Markus Horneber; Karen Steindorf Journal: Cancers (Basel) Date: 2022-04-15 Impact factor: 6.575